Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

University of California-San Diego

Superfund Research Program

Toxicogenomic Analysis of Nuclear Xenobiotic Receptors, PXR and CAR, in Chemical Metabolism and Human Health

Project Leader: Ronald M. Evans (Salk Institute for Biological Studies)
Grant Number: P42ES010337
Funding Period: 2005-2017

Learn More About the Grantee

Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Instagram page Visit the grantee's Facebook page Visit the grantee's Video page

Project Summary (2005-2010)

Xenobiotic nuclear receptors, PXR and CAR, are activated by numerous chemicals and induce the Phase I, II and III clearance pathways through their association with specific transcriptional coactivators. Although some environmental contaminants including those found in the Superfund sites are known to activate PXR, CAR or both in a species-specific manner, the effects of the receptor activation on the toxicity are not clear.The studies being conducted in this project are aimed at defining, in molecular terms, how the receptors and their xenobiotic and endobiotic ligands influence physiology by controlling gene expression patterns. The researchers' hypothesis is that certain toxic environmental agents activate either PXR and/or CAR, leading to both acute and chronic perturbations of the enterohepatic clearance system, production of supertoxic metabolites and endocrine disruption. To test these ideas, the researchers are combining genomic, molecular genetic, and biochemical approaches to:

  1. Identify environmental toxins that activate PXR and/or CAR using a high-throughput cell based reporter systems and an in vitro coactivator recruitment assay.
  2. Create a transgenic mouse line that replaces endogenous PXR with recombinant human PXR in both the liver and intestine to humanize the xenobiotic response over the entire enterohepatic system.
  3. Determine the contribution of PXR and CAR towards the long-term and acute toxicity of chemicals using knockout and transgenic humanized animals.
  4. Identify PXR and CAR target genes that contribute to the toxicogenomic response using DNA oligonucleotide microarray analysis.

Taken together, the proposed experiments are uncovering details of the molecular mechanisms by which environmental substances found at Superfund sites exert adverse effects and also provide unique and quantitative tools to predict toxicity.

Back
to Top